The double upgrade from Rothschild & Co adds a fresh bullish catalyst to an already bullish consensus, but the heavy insider and institutional selling creates a significant divergence that active traders should monitor closely. The stock's setup is a tug-of-war between analyst optimism and insider/institutional caution.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+20- T+0 · Oct 2 $97.50entry
- T+1 · 6w ago +2.67%α +1.99% · $100.10
- T+5 · 6w ago +2.15%α +0.99% · $99.60
- T+20 · 18d ago +8.92%α +10.73% · $106.20
- T+31 · todayOpen
- T+60 · in 6w Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Rothschild & Co double-upgraded ABT (ABBOTT LABORATORIES) from Neutral to Buy on October 2, 2026, raising the price target to $127 from $119. The new target implies 31.3% upside from the current price of $96.69. Rothschild & Co has a 54% accuracy rate on 52 scored calls with an average return of 2.9%. The consensus on ABT is heavily bullish: 25 analysts cover the stock, with 12 Strong Buy, 13 Buy, and 8 Hold ratings, zero Sell or Strong Sell. The mean price target is $120.26, median $120, with a high of $135 and low of $103. Rothschild's $127 target sits above the mean and median, reflecting an above-consensus bullish view. Over the past 30 days, ABT has seen 2 upgrades and 0 downgrades, while EPS revisions for the current quarter show 7 upward and 10 downward revisions, a mixed near-term signal. Insider selling has been significant, including a $25.3M sale by Ford Robert B on August 25, 2026, and institutional trimming by major funds including JPMorgan (-43.6%) and Capital Research (-25.8%). The double upgrade from a mid-accuracy firm with a target above consensus is a notable bullish catalyst, but heavy insider and institutional selling creates a conflicting signal. The bottom line: Rothschild's contrarian double upgrade adds momentum to an already bullish consensus, but the heavy insider and institutional selling warrants caution.
Impact Score
Consensus & Targets
The consensus among 25 analysts covering ABT is heavily bullish: 12 Strong Buy, 13 Buy, 8 Hold, 0 Sell, 0 Strong Sell. This represents 100% of ratings on the bullish side (Buy or Strong Buy), with no bearish ratings. The consensus direction is strongly positive.
Current price is $96.69. The mean price target is $120.26, median $120, high $135, low $103. Implied upside to the mean is 24.4%. Rothschild & Co's $127 target is above both the mean and median, indicating a more bullish stance than the average analyst. The target range spans $103 to $135, with Rothschild's target in the upper third.
Recent Analyst Activity
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-10-02 | Rothschild & Co | upgrade | Buy | $127.00 |
| 2026-10-02 | Rothschild& Co | upgrade | Buy | $127.00 |
| 2026-09-08 | TD Cowen | reiterate | Buy | $135.00 |
| 2026-08-25 | TD Cowen | maintain | Buy | No target |
| 2026-08-21 | TD Cowen | maintain | Buy | $135.00 |
| 2026-08-14 | Citigroup | maintain | Buy | No target |
| 2026-08-13 | Wolfe Research | upgrade | Outperform | $130.00 |
| 2026-07-28 | UBS | maintain | Buy | $125.00 |
| 2026-07-17 | Citigroup | maintain | Buy | $112.00 |
| 2026-07-17 | Piper Sandler | reiterate | Overweight | $118.00 |
Over the past 30 days, ABT has seen 2 upgrades and 0 downgrades. EPS revisions for the current quarter show 7 upward and 10 downward revisions in the last 30 days, a net negative revision trend. For the next quarter, revisions are strongly positive: 15 up and 0 down. For the current fiscal year, 5 up and 1 down. The mixed near-term revisions contrast with the bullish analyst action.
Firm Track Record: Rothschild & Co
Rothschild & Co accuracy: 54% on 52 calls | avg return: 2.9%
Industry benchmark: mean 51% ± 10%. Top tier: ≥61% (mean + 1σ). Based on 15 firms with ≥5 scored calls.
| Firm | Accuracy | Calls | Avg Return | vs Average |
|---|---|---|---|---|
| Stifel | 67% | 2/3 | 1% | top tier |
| Jefferies | 67% | 4/6 | 0.8% | top tier |
| Oppenheimer | 67% | 2/3 | -2.8% | top tier |
| Evercore ISI Group | 62% | 8/13 | 0% | top tier |
| RBC Capital | 58% | 7/12 | 1% | above average |
| Citigroup | 56% | 5/9 | -2.1% | above average |
| B of A Securities | 50% | 1/2 | 1.4% | below average |
| BTIG | 50% | 5/10 | -1.5% | below average |
| Benchmark | 50% | 1/2 | 0.1% | below average |
| Goldman Sachs | 50% | 2/4 | 7.8% | below average |
Rothschild & Co has a 54% accuracy rate on 52 scored calls with an average return of 2.9%. This places them in the middle of the pack among firms covering ABT. Top-tier firms by accuracy include Stifel (67% on 3 calls), Jefferies (67% on 6), and Oppenheimer (67% on 3). Lower-accuracy firms include Mizuho (33% on 3) and Piper Sandler (38% on 8). Rothschild's accuracy is slightly above the median for this coverage group.
Earnings Estimates
| Period | EPS Est. | EPS Range | Revenue | Revisions (7d) |
|---|---|---|---|---|
| 0q | $1.42 | $1.41 to $1.44 | $13.0B | ↑1 ↓0 |
| +1q | $1.64 | $1.59 to $1.67 | $13.5B | ↑1 ↓0 |
| 0y | $5.52 | $5.48 to $5.57 | $50.2B | ↑1 ↓0 |
| +1y | $6.07 | $5.88 to $6.20 | $54.5B | ↑1 ↓0 |
Cross-Platform Signals
Insider trading shows significant selling: Ford Robert B sold $25.3M and $20.9M on August 25, 2026, and Morrone Louis H. sold $642K on August 11. Congressional trades show three small sells (McCormick, Allen, Larsen) in July 2026. Institutional changes are uniformly negative: JPMorgan trimmed 43.6%, Capital Research trimmed 25.8%, Renaissance trimmed 44.6%, Bridgewater trimmed 48.9%. Short interest data shows a short ratio of 59.9% on off-exchange volume. The analyst upgrade is divergent from the heavy insider and institutional selling, creating a mixed cross-platform signal.
Investment Themes
Documents Analyzed
Report based on filing metadata.
Track record
38 reports on ABT
7 of 8 bullish or bearish reports moved the stock their way by T+20. Best: +17.16% at T+20 after the Jul 1, 2026 report. 8 of 9 went positive at some point.
Filters
- Nov 5, 202611d ago 144 Neutral 2/10 Entry $109.93 Now $107.45 −2.26% settles Dec 7
- Oct 27, 202620d ago ANALYST-DOWNGRADE Neutral 2/10 Entry $103.10 Now $107.45 +4.22% settles Nov 24
- Oct 27, 202621d ago Court Ruling Neutral 1/10 Entry $102.64 Now $107.45 +4.69% settles Nov 25
- Oct 21, 202626d ago Institutional Cluster Mixed 4/10 Entry $102.51 Now $107.45 +4.82% settles Nov 19
- Oct 21, 202626d ago 8-K Bullish 6/10 Entry $100.51 Now $107.45 +6.90% settles Nov 18
- Oct 21, 202626d ago 8-K Bearish 6/10 No price data
- Oct 21, 202626d ago Press Release Neutral 4/10 Entry $100.51 Now $107.45 +6.90% settles Nov 18
- Oct 20, 202628d ago Court Ruling Neutral 1/10 Entry $100.51 Now $107.45 +6.90% settles Nov 18
- Oct 16, 20264w ago Court Ruling Neutral 2/10 Entry $104.06 to $107.45 Now $107.45 +3.26% ▲ +3.26% +6.72% vs SPY
- Oct 15, 20264w ago Court Ruling Bullish 5/10 Entry $104.89 to $108.52 Now $107.45 +2.44% ▲ +3.46% +4.62% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers